Capsida Biotherapeutics

Description

Develops targeted genetic medicines and engineered capsids for neurological and ocular diseases, including IV-delivered CNS gene therapies and less invasive eye administration approaches.

Related

• Arbor BiotechnologiesDevelops gene editing treatments and genetic medicines using programmable DNA editors for people with genetic diseases, with a focus on CNS…
• Merck Cambridge Discovery ($MRK)Develops medicines and vaccines through research, clinical trials, and publications, focusing on diseases including cancer, infectious,…
• Krystal Biotech ($KRYS)Develops and delivers redosable genetic medicines, including VYJUVEK for dystrophic epidermolysis bullosa, using engineered HSV-1 vectors…
• Verge GenomicsBuilds AI models and discovery tools using multimodal human CNS data to identify drug targets, match patients, and support neurological…
• Dyno TherapeuticsBuilds high-performance genetic technologies to improve AAV gene delivery for gene therapy, supporting therapeutic developers working on…
• Editas Medicine ($EDIT)Develops CRISPR-based gene editing medicines, including in vivo approaches, for people with serious diseases where modifying genes may…
• Tessera TherapeuticsDevelops Gene Writing technology and non-viral delivery methods to make targeted genome alterations for therapies addressing major unmet…
• Sana Biotechnology ($SANA)Builds engineered cell medicines that repair or control genes, or replace damaged cells, for patients with diseases including diabetes,…
• Intuitive Surgical ($ISRG)Builds robotic-assisted surgical systems for minimally invasive procedures, helping surgeons perform operations more effectively with less…
• Neumora TherapeuticsDevelops treatments for brain diseases, advancing CNS-targeted medicines and precision approaches to understand disease biology and…
• Cabaletta Bio ($CABA)Develops engineered T cell therapies for autoimmune diseases, including rese-cel in Phase 1/2 trials for lupus, myositis, systemic…
• Relay Therapeutics ($RLAY)Develops small molecule medicines using computational and experimental protein-motion analysis, targeting previously hard-to-drug precision…